Morepen Laboratories Limited was incorporated in 1984. Its products include Loratadine, Montelukast Sodium, Atorvastatin Calcium and Sultamicillin. The company markets formulation products in various therapeutic categories, such as antibiotics, gastrointestinal, respiratory, analgesic, antiallergic and neuropsychiatry with brands, such as Saltum, Saltumax, Cefpopen, Cefpen-S, Dom-DT, Acifix, Rabipen- DSR and Montelast. It has new products added to the therapeutic categories, including Kilbac, Ducal D, Aclomore and Montelast-L. The company has three state-of-the-art manufacturing plants in the northern state of Himachal Pradesh (HP) in India. The main plant at Parwanoo is inspected and approved by United States Food and Drug Administration (USFDA) for production of Loratadine, which is the best selling anti-allergy drug globally. The company has filed 14 patents including 6 international PCT applications. The company has filed an international patent on a new amorphous form of the cholesterol-reducing drug Lipitor (Atorvastatin) that is the largest selling drug in the world.
Morepen Laboratories is one of the fastest growing companies of the stock market and is listed on BSE and NSE.
Below you will find details about Morepen Laboratories Company Profile, Share Price, News, Address, Management, Registrar and Contact Details.
|
|
409, 4th Floor, Antriksh Bhawan 22, Kasturba Gandhi Marg
New Delhi - 110001
Delhi - India
Phone : 23324443, 23712025
Fax : 23722422
|
